Decoding age-stratified clinical and molecular heterogeneity in male breast cancer through multiomic profiling.
Objective Age-associated molecular heterogeneity is well described in female breast cancer but remains insufficiently characterized in male breast cancer (MBC). We profiled age-stratified clinical and molecular differences between younger (≤55 years) male breast cancer (YMBC) and older (>55 years) male breast cancer (O...